Home > PE Ratio > ORCHID PHARMA

ORCHID PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ORCHID PHARMA is 44.26.

Share Price ₹708.9Sep 16,2025
Market Cap ₹3,594.1 Cr
Earnings-TTM₹81.2 CrTTM-Consolidated Results
Price/Earnings44.26xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of ORCHID PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ORCHID PHARMA is calculated as :

Current Market Cap [ ₹3,594.1 Cr] as on Sep 16,2025

(/) Earnings [ ₹81.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.26x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ORCHID PHARMA , the investors are currently willing to pay 44.26 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ORCHID PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ORCHID PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of ORCHID PHARMA


PE Ratio Performance Analysis for ORCHID PHARMA

- ORCHID PHARMA 's latest p/e ratio is 44.26x.

- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.19x.

- ORCHID PHARMA 's operated at median p/e ratio of 33.87x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2024 at 57.52x.

- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does ORCHID PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ORCHID PHARMA 81.2044.263,594.1
SUN PHARMACEUTICAL INDUSTRIES LTD10,411.5037.12386,497.0
DIVIS LABORATORIES LTD2,306.0070.16161,787.0
CIPLA LTD5,406.8123.28125,870.0
TORRENT PHARMACEUTICALS LTD2,002.0059.74119,591.0
DR REDDYS LABORATORIES LTD5,726.7019.10109,380.0
MANKIND PHARMA LTD1,905.5155.65106,044.0
ZYDUS LIFESCIENCES LTD4,637.8022.46104,145.0
LUPIN LTD3,722.1825.1793,694.0
AUROBINDO PHARMA LTD3,417.9318.5663,420.6
ABBOTT INDIA LTD1,452.2945.3165,799.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ORCHID PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.56x
Max industry PE 70.16x
Median industry PE 37.12x
Average industry PE 38.25x



You may also like the below Video Courses